MAPT and Alzheimer disease: CSF evaluation revealed high likelihood of Alzheimer pathology in 6 patients (AT index < 1, 85–94% sensitivity and 83–89% specificity distinguishing Alzheimer’s disease from non-Alzheimer’s disease, phospho-Tau concentration > 61 pg/m).